Lidocaine 5% patch 30S

Ended Awarded Last action

Contract number
SPE2DR26FJF4H
Awardee
Awarding agency
Obligated
$15,405

Award facts

Contract value 100% obligated
$15,405.33 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $15,405.33 and utilizes firm fixed-price pricing, with a completion date of December 30, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. This delivery order is issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables supply of pharmaceuticals and medical supplies to military healthcare programs worldwide.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capacity to supply a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The Lidocaine patch procurement represents a routine component of the company's ongoing support to military medical supply chains, consistent with DLA's strategic pharmaceutical procurement approach, which includes planning for multiple-award contracts under the emerging Pharmaceutical Prime Vendor Global Program Generation V initiative to serve regional healthcare requirements.

Quick answers

Who was awarded contract SPE2DR26FJF4H?

SPE2DR26FJF4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.

How much is contract SPE2DR26FJF4H worth?

The government has obligated $15,405 on SPE2DR26FJF4H.

Is contract SPE2DR26FJF4H an order under another contract?

Yes. SPE2DR26FJF4H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.

Was contract SPE2DR26FJF4H competed?

The extent of competition for SPE2DR26FJF4H was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award